This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Salk Institute for Biological Studies. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: William Partlo and Selective Oncolytic Adenovirus Research.
Introduction
William Partlo is an inventor associated with the Salk Institute for Biological Studies in San Diego, California. His patent work concerns an oncolytic adenovirus designed to replicate selectively according to the status of p53 transcriptional activity.
Latest Patents
Partlo is listed as an inventor on one patent: “Oncolytic Adenovirus with Replication Selectivity Based on Status of p53 Transcriptional Activity.” The invention describes an approach to controlling viral replication based on p53 activity.
Career Highlights
Partlo’s listed patent reflects work at the intersection of virology and cancer research. His association with the Salk Institute connects this invention to the institute’s research environment.
Collaborations
Partlo’s listed coworker is Clodagh O’Shea, who is also associated with the Salk Institute for Biological Studies.
Conclusion
William Partlo’s patent contribution focuses on selective oncolytic adenovirus replication, linking his inventor profile to cancer research at the Salk Institute.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile